• 15 hours ago • 3 Mins Read The move extends Abridge’s capabilities beyond ambient clinical documentation into claims management, coding, prior authorization, and research support. Healthcare AI company Abridge has secured a strategic investment from pharmaceutical major Eli Lilly and Company while unveiling a significant expansion of its platform to support payer, reimbursement, clinical…